Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease

Ronald B. DeMattos, Mark A. O'dell, Maia Parsadanian, Jennie W. Taylor, Judith A.K. Harmony, Kelly R. Bales, Steven M. Paul, Bruce J. Aronow, David M. Holtzman

Research output: Contribution to journalArticlepeer-review

264 Scopus citations

Abstract

Studies have shown that clusterin (also called apolipoprotein J) can influence the structure and toxicity of amyloid-β (Aβ) in vitro. To determine whether endogenous clusterin plays a role in influencing Aβ deposition, structure, and toxicity in vivo, we bred PDAPP mice, a transgenic mouse model of Alzheimer's disease, to clusterin-/- mice. By 12 months of age, PDAPP, clusterin-/- mice had similar levels of brain Aβ deposition as did PDAPP, clusterin+/+clusterin+'+ mice. Although Aβ deposition was similar, PDAPP, clusterin-/- mice had significantly fewer fibrillar Aβ (amyloid) deposits than PDAPP mice expressing clusterin. In the absence of clusterin, neuritic dystrophy associated with the deposited amyloid was markedly reduced, resulting in a dissociation between fibrillar amyloid formation and neuritic dystrophy. These findings demonstrate that clusterin markedly influences Aβ structure and neuritic toxicity in vivo and is likely to play an important role in Alzheimer's disease pathogenesis.

Original languageEnglish
Pages (from-to)10843-10848
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume99
Issue number16
DOIs
StatePublished - Aug 2002

Fingerprint

Dive into the research topics of 'Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease'. Together they form a unique fingerprint.

Cite this